U.S. Senator Marco Rubio (R-FL) spoke about worldwide threats to religious freedom at the International Republican Institute (IRI) John S. McCain Freedom Award Celebration. Senator Rubio presented this year’s award to Bishop Rolando Álvarez, a prominent victim of the...
News
Latest News
Rubio: DHS Must Do More to Fully Implement UFLPA
The U.S. Department of Homeland Security (DHS) has announced 26 additions to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List. While this is welcomed news, the Biden Administration has yet to include exporters who are tainting the United States’ supply chain...
Rubio-led Resolution to Raise Awareness of DIPG Pediatric Brain Cancer Passes Senate
Brain tumors are the leading cause of cancer-related death among children in our nation. Unfortunately, diffuse intrinsic pontine glioma (DIPG) is the leading form of pediatric brain cancer deaths. U.S. Senators Marco Rubio (R-FL) and Jack Reed (D-RI) led a...
ICYMI: Rubio Attacks Petro’s Backfiring Policies
Petro’s Backfiring Policies Imperil Two Decades of Colombian Progress U.S. Senator Marco Rubio (R-FL) May 14, 2024 Medium [As Colombian President Gustavo Petro] reneges on his campaign promises and prepares to rewrite the Colombian constitution in his favor, his...
Por Si Se Lo Perdió: Rubio sobre las Políticas Contraproducentes de Petro
Políticas del presidente Gustavo Petro ponen en peligro dos décadas de progreso en Colombia 16 de mayo del 2024 El Tiempo El 6 de mayo el grupo terrorista ELN, una vez más, anunció que retomaba los secuestros porque el gobierno colombiano no cedió a sus demandas...
Rubio: Foreign Influence Will Be a Part of Political Debates, Not Just Elections
U.S. Senate Select Committee on Intelligence Vice Chairman Marco Rubio (R-FL) delivered closing remarks at a hearing on foreign threats to the 2024 elections. “I just know that this is going to get far more complex, and I predict it won't just be about elections, it...
Intelligence Committee Vice Chair and Chair Push to Counter China in Critical Technology Sectors
U.S. Senators Marco Rubio (R-FL) and Mark Warner (D-VA), Vice Chairman and Chairman, respectively, of the Senate Select Committee on Intelligence sent a letter to U.S. Secretary of Commerce Gina Raimondo expressing the urgent need to strengthen the Commerce Department’s actions to protect U.S. critical technologies – including the biotech sector – through a more robust and resilient export-control regime, among other measures.
- “We write to underscore our continued concern that the Department of Commerce has not sufficiently used its existing tools, including export controls, to prevent adversary access to U.S. technology, capital, data, and talent in critical technology sectors.
- “We urge the Commerce Department, in cooperation with the Treasury Department and the Intelligence Community, to take a comprehensive approach to protecting American technology, investment, data, and talent in critical technology sectors, such as biotechnology. Specifically, the Commerce Department should implement an export-control regime targeting the biotechnology sector—as undertaken with the semiconductor industry—and impose controls on the sharing of American data.”
Flashback…This letter follows previous efforts from Senators Rubio and Warner to push the Departments of Treasury and Commerce to counter the flow of U.S. technology and investments to the People’s Republic of China (PRC)’s military industrial complex.
The full text of the letter is below.
Dear Secretary Raimondo:
We write to underscore our continued concern that the Department of Commerce has not sufficiently used its existing tools, including export controls, to prevent adversary access to U.S. technology, capital, data, and talent in critical technology sectors. Last February, in our capacity as Chairman and Vice Chairman of the Senate Select Committee on Intelligence, we wrote to you on this topic and have yet to receive a reply. As such, we renew our request for the Department of Commerce to increase its actions to protect U.S. critical technologies, including in the biotechnology sector, through a more robust export-control regime, among other measures.
In our February 9, 2023 letter, we highlighted the continued efforts by the People’s Republic of China (PRC) to target American technology, investment, and data in order to monopolize global supply chains, achieve technological dominance, and displace U.S. economic and military leadership. We urged the Department to use its authorities to track PRC efforts to acquire U.S. innovation, and immediately restrict these activities.
The PRC has continued its attempts to leverage the lack of U.S. controls surrounding access to American innovation, data, and talent to undermine U.S. superiority in critical sectors and related supply chains. The PRC has capitalized on the massive amounts of U.S. data and innovation it has acquired to develop weapons and technologies for nefarious ends.
We were pleased to see the Department of Commerce add 37 entities, including Beijing Genomics Institute (BGI) Research, BGI Tech Solutions, and Forensic Genomics International, to its Entity List in March 2023. The U.S. government, however, continues to allow PRC biotechnology companies to operate freely within the U.S., to purchase and/or invest in U.S. companies, and to acquire U.S. data. These companies include: BGI Group, MGI Tech, Complete Genomics, WuXi AppTech, and WuXi Biologics, which have linkages to the People’s Liberation Army (PLA), the Chinese Communist Party’s (CCP) Military-Civil Fusion program, and/or to the PRC’s ongoing genocide in the Xinjiang Uyghur Autonomous Region. For example, BGI has purchased American companies and leveraged these American companies to provide machines to unwitting U.S. laboratories and obtain sensitive genetic data of Americans.
We urge the Commerce Department, in cooperation with the Treasury Department and the Intelligence Community, to take a comprehensive approach to protecting American technology, investment, data, and talent in critical technology sectors, such as biotechnology. Specifically, the Commerce Department should implement an export-control regime targeting the biotechnology sector —as undertaken with the semiconductor industry—and impose controls on the sharing of American data. The CCP has openly revealed its intentions to utilize biotechnology to advance its military capabilities and ambitions, undermine U.S. security, and continue its egregious violations of human rights. The U.S. must respond forcefully to these intentions. While the Department has ample authorities to take action, we commit to working with the Department if additional legislation is needed to secure American interests in biosecurity.
Sincerely,